Dasolampanel etibutil is a novel selective ionotropic glutamate receptor 5 (iGluR5) antagonist. References: Petersen KL, Iyengar S, Chappell AS, Lobo ED, Reda H, Prucka WR, Verfaille SJ. Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers. Pain. 2014 May;155(5):929-36. doi: 10.1016/j.pain.2014.01.019. Epub 2014 Jan 31. PubMed PMID: 24486883.

纯度：≥98%

CAS：503291-52-9